Institut Catala d Oncologia L Hospitalet

L'Hospitalet de Llobregat 08908

0 studies enrolling now · 1 studies all time

What they study most

Relapsed or Refractory Multiple Myeloma

Studies at this site

• A Study Comparing Teclistamab Monotherapy Versus Pomalidomide, Bortezomib, Dexamethasone (PVd) or Carfilzomib, Dexamethasone (Kd) in Participants With Relapsed or Refractory Multiple Myeloma — Running, not enrolling